These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1352397)
1. erbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling. Segatto O; Lonardo F; Helin K; Wexler D; Fazioli F; Rhee SG; Di Fiore PP Oncogene; 1992 Jul; 7(7):1339-46. PubMed ID: 1352397 [TBL] [Abstract][Full Text] [Related]
2. The role of autophosphorylation in modulation of erbB-2 transforming function. Segatto O; Lonardo F; Pierce JH; Bottaro DP; Di Fiore PP New Biol; 1990 Feb; 2(2):187-95. PubMed ID: 1982072 [TBL] [Abstract][Full Text] [Related]
3. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities. Liu SM; Carpenter G J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224 [TBL] [Abstract][Full Text] [Related]
4. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. Lonardo F; Di Marco E; King CR; Pierce JH; Segatto O; Aaronson SA; Di Fiore PP New Biol; 1990 Nov; 2(11):992-1003. PubMed ID: 1983208 [TBL] [Abstract][Full Text] [Related]
5. The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. Sorkin A; Di Fiore PP; Carpenter G Oncogene; 1993 Nov; 8(11):3021-8. PubMed ID: 8105439 [TBL] [Abstract][Full Text] [Related]
6. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential. Zhang HT; O'Rourke DM; Zhao H; Murali R; Mikami Y; Davis JG; Greene MI; Qian X Oncogene; 1998 Jun; 16(22):2835-42. PubMed ID: 9671404 [TBL] [Abstract][Full Text] [Related]
7. Transforming potentials of epidermal growth factor and nerve growth factor receptors inversely correlate with their phospholipase C gamma affinity and signal activation. Obermeier A; Tinhofer I; Grunicke HH; Ullrich A EMBO J; 1996 Jan; 15(1):73-82. PubMed ID: 8598208 [TBL] [Abstract][Full Text] [Related]
8. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor. Komada M; Kitamura N Oncogene; 1993 Sep; 8(9):2381-90. PubMed ID: 7689722 [TBL] [Abstract][Full Text] [Related]
9. A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2. Pei Z; Maloney JA; Yang L; Williamson JR Arch Biochem Biophys; 1997 Sep; 345(1):103-10. PubMed ID: 9281317 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020 [TBL] [Abstract][Full Text] [Related]
11. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways. Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953 [TBL] [Abstract][Full Text] [Related]
12. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity. Hauguel-DeMouzon S; Csermely P; Zoppini G; Kahn CR J Cell Physiol; 1992 Jan; 150(1):180-7. PubMed ID: 1730782 [TBL] [Abstract][Full Text] [Related]
13. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y; Li X; Jiang J; Frank SJ Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991 [TBL] [Abstract][Full Text] [Related]
14. The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. Fazioli F; Kim UH; Rhee SG; Molloy CJ; Segatto O; Di Fiore PP Mol Cell Biol; 1991 Apr; 11(4):2040-8. PubMed ID: 1672440 [TBL] [Abstract][Full Text] [Related]
16. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling. Wong L; Deb TB; Thompson SA; Wells A; Johnson GR J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134 [TBL] [Abstract][Full Text] [Related]
17. EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity. Fan YX; Wong L; Johnson GR Biochem J; 2005 Dec; 392(Pt 3):417-23. PubMed ID: 16122376 [TBL] [Abstract][Full Text] [Related]
18. Autophosphorylation of the intracellular domain of the epidermal growth factor receptor results in different effects on its tyrosine kinase activity with various peptide substrates. Phosphorylation of peptides representing Tyr(P) sites of phospholipase C-gamma. Hsu CY; Hurwitz DR; Mervic M; Zilberstein A J Biol Chem; 1991 Jan; 266(1):603-8. PubMed ID: 1845982 [TBL] [Abstract][Full Text] [Related]
19. The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. Di Fiore PP; Segatto O; Lonardo F; Fazioli F; Pierce JH; Aaronson SA Mol Cell Biol; 1990 Jun; 10(6):2749-56. PubMed ID: 2188097 [TBL] [Abstract][Full Text] [Related]
20. The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation. Kim H; Chan R; Dankort DL; Zuo D; Najoukas M; Park M; Muller WJ Oncogene; 2005 Nov; 24(51):7599-607. PubMed ID: 16170374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]